Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	464.21	429.43	367.25	539.4	200.71	369.6
Depreciation & Amortization	21.7	22.79	30.49	31.8	34.73	35.14
Other Amortization	0.38	0.38	0.4	0.51	0.82	0.68
Loss (Gain) From Sale of Assets	0.57	-	0.01	-	0	-11.33
Loss (Gain) From Sale of Investments	-24.88	-38.73	46.68	-241.86	22.7	-261.05
Loss (Gain) on Equity Investments	8.19	9.25	-52.09	-	-	-
Stock-Based Compensation	67.48	62.4	-	-	0.79	2.14
Other Operating Activities	33.01	-31.4	69.34	63.59	32.04	26.66
Change in Accounts Receivable	-41.29	-35.48	-93.36	-16.94	-51.1	-17.62
Change in Inventory	-7.76	4.33	-10.95	19.22	-31.53	-21.28
Change in Accounts Payable	8.32	18.28	1.8	-5.74	14.08	9.96
Change in Unearned Revenue	68.15	96.85	72.48	31.76	77.68	8.09
Change in Other Net Operating Assets	-19.51	-1.76	8.29	0.01	18.27	-5.29
Operating Cash Flow	578.56	536.35	440.34	421.74	319.2	135.69
Operating Cash Flow Growth	-1.81%	21.80%	4.41%	32.12%	135.25%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-0.95	-1.28	-4.85	-5.82	-3.19	-1.98
Sale of Property, Plant & Equipment	-	-	-	-	-	28.1
Sale (Purchase) of Intangibles	-0.1	-4.44	-0.71	-0.02	-2.41	-2.67
Investment in Securities	164.96	183.02	22.76	64.31	-279.19	-316.21
Other Investing Activities	-0.19	-43.03	-40.67	3.12	-2.52	-4.06
Investing Cash Flow	182.13	134.27	-23.46	61.6	-287.31	-296.83

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	250	-	-	-	-
Total Debt Issued	250	250	-	-	-	-
Short-Term Debt Repaid	-	-250	-	-	-	-
Long-Term Debt Repaid	-	-10.71	-11.59	-11.92	-11.11	-10.02
Lease Payments	-10.19	-10.71	-11.59	-11.92	-11.11	-10.02
Total Debt Repaid	-260.19	-260.71	-11.59	-11.92	-11.11	-10.02
Net Debt Issued (Repaid)	-10.19	-10.71	-11.59	-11.92	-11.11	-10.02
Issuance of Common Stock	0.27	0.27	0.02	4.04	2.37	745.29
Repurchase of Common Stock	-179.41	-349.42	-	-356.35	-	-
Common Dividends Paid	-339.21	-407.8	-440.03	-136.29	-309.49	-
Other Financing Activities	-0.48	17.54	-0.04	0.06	-1.2	-1.9
Financing Cash Flow	-529.02	-750.13	-451.64	-500.47	-319.43	733.36

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	231.67	-79.51	-34.77	-17.13	-287.53	572.22

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	577.61	535.07	435.49	415.92	316.02	133.7
Free Cash Flow Growth	-1.72%	22.87%	4.70%	31.61%	136.35%	-
Free Cash Flow Margin	50.69%	52.59%	46.63%	54.84%	50.36%	30.47%
Free Cash Flow Per Share	5.86	5.79	4.67	4.39	3.30	1.40
Levered Free Cash Flow	463.19	406.49	290.39	304.48	219.61	100.32
Unlevered Free Cash Flow	464.17	407.07	290.47	304.6	219.92	100.7
Free Cash Flow After Leases	567.42	524.35	423.9	404	304.91	123.68

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.92	0.92	0.13	0.2	0.51	0.62
Cash Income Tax Paid	118.93	118.93	68.57	19.66	31.17	0.04
Change in Working Capital	7.9	82.22	-21.74	28.3	27.4	-26.15

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error